Skip to main content

Table 1 General characteristics of patients

From: Beta-trace protein as a potential biomarker of residual renal function in patients undergoing peritoneal dialysis

patients in total

29

sex (male / female)

18/11

age (years)

52.7 ± 12.15

body weight (kg)

81.16 (SD ± 14.96)

body mass index

26.88 (SD ± 4.55)

residual diuresis (ml)

1374 (SD ± 913)

PD regime (CAPD)

29

serum BTP (mg/L)

8.16 (SD ± 4.75)

serum Cystatin C (mg/L)

5.78 (SD ± 1.6)

serum urea (mg/dL)

123.5 (SD ± 70.3)

serum creatinine (mg/dL)

8.83 (SD ± 3.59)

dialysate volume (L)

8.86 (SD ± 1.9)

dialysate BTP (mg/L)

0.54 (SD ± 0.34)

dialysate Cystatin C (mg/L)

0.64 (SD ± 0.35)

dialysate urea (mg/dL)

107.9 (SD ± 42.01)

dialysate creatinine (mg/dL)

7.03 (SD ± 9.4)

urine BTP (mg/L)

14.7 (SD ± 9.58)

urine Cystatin C (mg/L)

5.44 (SD ± 4.53)

urine urea (mg/dL)

382.89 (SD ± 232.2)

urine creatinine (mg/dL)

51.12 (SD ± 36.81)

weekly Kt/V

2.28 (SD ± 0.76)

weekly peritoneal Kt/V

1.4 (SD ± 0.49)

weekly renal Kt/V

0.86 (SD ± 0.65)

total creatinine clearance (L/week/1,73 m2)

91 (SD ± 51.61)

renal creatinine clearance (L/week/1,73 m2)

54.82 (SD ± 52.87)

peritoneal creatinine clearance (L/week/1,73 m2)

34.29 (SD ± 12.49)

  1. General characteristics of patients and treatment modality. Data are given as mean and standard deviation